Asymmetric dimethylarginine as a novel independent risk factor for cardiovascular disease in hemodialysis patients

被引:0
|
作者
Cibulka, R. [1 ]
Siroka, R. [1 ]
Rajdl, D. [1 ]
Racek, J. [1 ]
机构
[1] Charles Univ Hosp, Inst Clin Biochem & Hematol, Plzen, Czech Republic
关键词
D O I
10.1016/S1567-5688(06)81215-8
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
TuP10515
引用
收藏
页码:298 / 298
页数:1
相关论文
共 50 条
  • [31] Early failure of arteriovenous fistula is an independent risk factor of cardiovascular mortality in hemodialysis patients
    Kim, Young Ok
    Shin, Young Shin
    Kim, Byung Soo
    Song, Ho Cheol
    Yoon, Sun Ae
    Lee, Seung Hun
    Kim, Yong Soo
    Kim, Suk Young
    Choi, Euy Jin
    Chang, Yoon Sik
    Bang, Byung Kee
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 216 - 216
  • [32] SERUM LIPOPROTEIN(A) AS AN INDEPENDENT CARDIOVASCULAR RISK FACTOR FOR PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS
    DOCCI, D
    MANZONI, G
    BALDRATI, L
    CAPPONCINI, C
    NERI, L
    FELETTI, C
    NEPHRON, 1995, 69 (02): : 195 - 195
  • [33] Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease
    Liu, Xiaohong
    Xu, Xin
    Shang, Rum
    Chen, Yingjie
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2018, 78 : 113 - 120
  • [34] Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease
    Dragicevic, Maro
    Kosuta, Iva
    Kruezi, Egon
    Lovrencic, Marijana Vucic
    Mrzljak, Anna
    MEDICINA-LITHUANIA, 2020, 56 (11): : 1 - 11
  • [35] Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients
    Kanbay, Mehmet
    Afsar, Baris
    Siriopol, Dimitrie
    Unal, Hilmi Umut
    Karaman, Murat
    Saglam, Mutlu
    Eyileten, Tayfun
    Gezer, Mustafa
    Verim, Samet
    Oguz, Yusuf
    Vural, Abdulgaffar
    Ortiz, Alberto
    Johnson, Richard J.
    Covic, Adrian
    Yilmaz, Mahmut Ilker
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (07) : 1129 - 1136
  • [36] Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients
    Mehmet Kanbay
    Baris Afsar
    Dimitrie Siriopol
    Hilmi Umut Unal
    Murat Karaman
    Mutlu Saglam
    Tayfun Eyileten
    Mustafa Gezer
    Samet Verim
    Yusuf Oguz
    Abdulgaffar Vural
    Alberto Ortiz
    Richard J. Johnson
    Adrian Covic
    Mahmut Ilker Yilmaz
    International Urology and Nephrology, 2016, 48 : 1129 - 1136
  • [37] Serum fetuin-A levels: A novel cardiovascular risk factor in hemodialysis patients
    Ali, Deniz
    Rahmi, Yilmaz
    Alper, Kirkpantur
    Orcun, Ciftci
    Hakan, Emmungil
    Bulent, Altun
    Mustala, Arici
    Yunus, Erdem
    Lale, Tokgozoglu
    Unal, Yasavul
    Cetin, Turgan
    CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 : S29 - S29
  • [38] Subclinical disease as an independent risk factor for cardiovascular disease
    Friedman, EH
    CIRCULATION, 1996, 94 (05) : 1138 - 1138
  • [39] Asymmetric dimethylarginine: a risk indicator or pathogenic factor?
    Fuchs, Dietmar
    Kurz, Katharina
    Gostner, Johanna M.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2016, 126 (09): : 621 - 622
  • [40] Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine
    Ghebremariam, Yohannes T.
    LePendu, Paea
    Lee, Jerry C.
    Erlanson, Daniel A.
    Slaviero, Anna
    Shah, Nigam H.
    Leiper, James
    Cooke, John P.
    CIRCULATION, 2013, 128 (08) : 845 - 853